Redeye: Tessin - Expected sales rebound delayed once again
Redeye updates its estimates after reviewing Tessin's Q1 report, which came in below expectations. The weaker-than-expected results are mainly due to the limited impact from the Pollen Street agreement, which has yet to deliver the anticipated positive effect. Redeye revises its estimates and valuation on the back of the report.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/